This includes the U.S. launch of Avitene Flowable, a next-generation flowable hemostat that strengthens our position in biosurgery and enters us into a nearly $400 million market, growing ...

Becton, Dickinson and Co ((BDX)) has held its Q1 earnings call. Read on for the main highlights of the call. Becton, Dickinson and Co.’s latest earnings call struck a cautiously upbeat tone, pairing ...

Adjusted EPS of $2.91 beat forecasts by 3.56%. Revenue reached $5.3 billion, surpassing expectations by 2.91%. Stock fell 2.49% in pre-market trading despite earnings beat. Operational margins ...

Becton Dickinson and Co. (NYSE:BDX) reported first-quarter fiscal 2026 results on February 9, beating analyst expectations despite facing margin pressures. The medical technology company posted ...

Hello, and welcome to BD's First Fiscal Quarter 2026 Earnings Call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website at ...